226 related articles for article (PubMed ID: 15802348)
1. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
Mueller-Brandes C; Holl RW; Nastoll M; Ballmann M
Eur Respir J; 2005 Apr; 25(4):715-7. PubMed ID: 15802348
[TBL] [Abstract][Full Text] [Related]
2. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
3. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
4. Comparison of differing diagnostic criteria for diabetes: experience from a New Zealand community laboratory.
Florkowski C; Thompson A
N Z Med J; 1999 Sep; 112(1095):339-41. PubMed ID: 10553936
[TBL] [Abstract][Full Text] [Related]
5. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
[TBL] [Abstract][Full Text] [Related]
6. Comparison of The World Health Organization (WHO) two-step strategy and OGTT for diabetes mellitus screening.
Adam JM; Tarigan NP
Acta Med Indones; 2004; 36(1):3-7. PubMed ID: 15931695
[TBL] [Abstract][Full Text] [Related]
7. [Glucose tolerance in patients with cystic fibrosis].
Thorsteinsson SL; Hansen A; Thorsteinsson B; Nerup J; Koch C
Ugeskr Laeger; 1996 Oct; 158(44):6269-73. PubMed ID: 8966811
[TBL] [Abstract][Full Text] [Related]
8. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of cystic fibrosis related diabetes: a selective approach in performing the oral glucose tolerance test based on a combination of clinical and biochemical criteria.
Yung B; Kemp M; Hooper J; Hodson ME
Thorax; 1999 Jan; 54(1):40-3. PubMed ID: 10343630
[TBL] [Abstract][Full Text] [Related]
10. Glucose intolerance in cystic fibrosis patients.
Lanng S
Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
[TBL] [Abstract][Full Text] [Related]
11. Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program.
Sterescu AE; Rhodes B; Jackson R; Dupuis A; Hanna A; Wilson DC; Tullis E; Pencharz PB
J Pediatr; 2010 Apr; 156(4):613-7. PubMed ID: 19962154
[TBL] [Abstract][Full Text] [Related]
12. Performance indicators and validity of serum fructosamine assay as a diagnostic test in a screening program for diabetes mellitus.
Mula-Abed WA; Al-Naemi AH
Saudi Med J; 2003 May; 24(5):477-84. PubMed ID: 12847621
[TBL] [Abstract][Full Text] [Related]
13. [Impact of lowering the cut-point for impaired fasting glucose on the distribution of impaired glucose regulation subcategories in Chinese adult population].
Yang ZJ; Yang WY; Xiao JZ; Li GW; Wang Y
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1773-6. PubMed ID: 15631770
[TBL] [Abstract][Full Text] [Related]
14. Use of hemoglobin A1c to identify dysglycemia in cystic fibrosis.
Darukhanavala A; Van Dessel F; Ho J; Hansen M; Kremer T; Alfego D
PLoS One; 2021; 16(4):e0250036. PubMed ID: 33882078
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of cystic fibrosis-related diabetes.
Brennan AL; Geddes DM; Gyi KM; Baker EH
J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
[TBL] [Abstract][Full Text] [Related]
16. [Significance of 2-hour blood glucose after standardized steamed bread meal in diabetic screening].
Liu Y; Tian H; Fang F; Xiao H; Lu Y; Shao Y; Li C
Zhonghua Yi Xue Za Zhi; 2014 May; 94(18):1388-92. PubMed ID: 25142989
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of glucose tolerance in cystic fibrosis: comparison of 50-g and 75-g tests.
Lee KM; Miller RJ; Rosenberg FM; Kreisman SH
J Cyst Fibros; 2007 Jul; 6(4):274-6. PubMed ID: 17161660
[TBL] [Abstract][Full Text] [Related]
18. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
[TBL] [Abstract][Full Text] [Related]
19. Microvascular complications in cystic fibrosis-related diabetes.
Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A
Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485
[TBL] [Abstract][Full Text] [Related]
20. Improving screening for cystic fibrosis-related diabetes at a pediatric cystic fibrosis program.
Kern AS; Prestridge AL
Pediatrics; 2013 Aug; 132(2):e512-8. PubMed ID: 23821699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
